Endocrine disorders in mitochondrial disease

被引:76
|
作者
Schaefer, Andrew M. [1 ]
Walker, Mark [2 ]
Turnbull, Douglass M. [1 ]
Taylor, Robert W. [1 ]
机构
[1] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
基金
英国惠康基金;
关键词
Mitochondrial disease; Endocrine; mtDNA; Diabetes; m.3243A > G; KEARNS-SAYRE-SYNDROME; HEREDITARY OPTIC NEUROPATHY; GROWTH-HORMONE DEFICIENCY; DNA A3243G MUTATION; TO-G MUTATION; TYPE-2; DIABETES-MELLITUS; LACTIC-ACIDOSIS; TRNA(LEU(UUR)) GENE; MTDNA MUTATION; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY;
D O I
10.1016/j.mce.2013.06.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Endocrine dysfunction in mitochondrial disease is commonplace, but predominantly restricted to disease of the endocrine pancreas resulting in diabetes mellitus. Other endocrine manifestations occur, but are relatively rare by comparison. In mitochondrial disease, neuromuscular symptoms often dominate the clinical phenotype, but it is of paramount importance to appreciate the multi-system nature of the disease, of which endocrine dysfunction may be a part. The numerous phenotypes attributable to pathogenic mutations in both the mitochondrial (mtDNA) and nuclear DNA creates a complex and heterogeneous catalogue of disease which can be difficult to navigate for novices and experts alike. In this article we provide an overview of the endocrine disorders associated with mitochondrial disease, the way in which the underlying mitochondrial disorder influences the clinical presentation, and how these factors influence subsequent management. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:2 / 11
页数:10
相关论文
共 50 条
  • [41] Mitochondrial disease: genetics and management
    Ng, Yi Shiau
    Turnbull, Doug M.
    JOURNAL OF NEUROLOGY, 2016, 263 (01) : 179 - 191
  • [42] Mitochondrial disorders: aetiologies, models systems, and candidate therapies
    Farrar, G. Jane
    Chadderton, Naomi
    Kenna, Paul F.
    Millington-Ward, Sophia
    TRENDS IN GENETICS, 2013, 29 (08) : 488 - 497
  • [43] Mitochondrial disorders of the OXPHOS system
    Fernandez-Vizarra, Erika
    Zeviani, Massimo
    FEBS LETTERS, 2021, 595 (08) : 1062 - 1106
  • [44] Gene therapy for mitochondrial disorders
    Keshavan, Nandaki
    Minczuk, Michal
    Viscomi, Carlo
    Rahman, Shamima
    JOURNAL OF INHERITED METABOLIC DISEASE, 2024, 47 (01) : 145 - 175
  • [45] Mitochondrial Etiology of Neuropsychiatric Disorders
    Pei, Liming
    Wallace, Douglas C.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : 722 - 730
  • [46] Biomarkers for Detecting Mitochondrial Disorders
    Finsterer, Josef
    Zarrouk-Mahjoub, Sinda
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (02):
  • [47] Drugs interfering with mitochondrial disorders
    Finsterer, Josef
    Segall, Liane
    DRUG AND CHEMICAL TOXICOLOGY, 2010, 33 (02) : 138 - 151
  • [48] Single deletions in mitochondrial DNA - Molecular mechanisms and disease phenotypes in clinical practice
    Pitceathly, R. D. S.
    Rahman, S.
    Hanna, M. G.
    NEUROMUSCULAR DISORDERS, 2012, 22 (07) : 577 - 586
  • [49] Pathogenesis and Treatment of Mitochondrial Disorders
    DiMauro, Salvatore
    Hirano, Michio
    INHERITED NEUROMUSCULAR DISEASES: TRANSLATION FROM PATHMECHANISMS TO THERAPIES, 2009, 652 : 139 - 170
  • [50] Epidemiology and treatment of mitochondrial disorders
    Chinnery, PF
    Turnbull, DM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 106 (01): : 94 - 101